K. Reich, M. Goodfield, L. Green, K. Nograles, E. Levi, and R. G. Langley, “Safety and Efficacy of Apremilast Through 104 Weeks in Patients swith Moderate-to-Severe Psoriasis Who Continued on Apremilast or Switched from Etanercept Treatment in the LIBERATE Study”, J of Skin, vol. 1, no. 3.1, p. s32, Oct. 2017.